News

Tue, 06/10/2020
Dr. Beatrice Wasser awarded DGfI Herbert Fischer Prize for Neuroimmunology
Each year, the German Society for Immunology (DGfI) recognizes young scientists who have made an outstanding contribution in the field of immunology. This year, Dr. Beatrice Wasser, a Postdoc in the group of Prof. Frauke Zipp and Prof. Stefan Bittner in the Department of Neurology, was award the Herbert Fischer Prize for Neuroimmunology for her […]...more
Tue, 08/09/2020
Study with identical twins shows that the early form of multiple sclerosis has a specific pattern
The tremendous heterogeneity of the human population presents a major obstacle in understanding how autoimmune diseases like multiple sclerosis (MS) contribute to variations in human peripheral immune signatures. To minimize heterogeneity, SFB researchers from Munich and Muenster made use of a unique cohort of 43 monozygotic twin pairs clinically discordant for MS and searched for […]...more
Mon, 09/03/2020
Breakthrough: SFB scientsists explain pathomechanism of Susac Syndrome
Münster. Neuroinflammation is often associated with blood-brain-barrier dysfunction, which contributes to neurological tissue damage. In a paper published in the renowned journal Nature Communications SFB 128 scientists from Mueenster reveal the pathophysiology of Susac syndrome (SuS), an enigmatic neuroinflammatory disease with central nervous system (CNS) endotheliopathy. By investigating immune cells from the blood, cerebrospinal fluid, […]...more


Thu, 09/11/2017 | Elisabeth Schuh received SEED funding

Munich. SFB 128 researcher Elisabeth Schuh, MD, has been honoured by a young scientist’s studentship within the KKNMS SEED program. In her project „The role of the NLRP3 inflammasome in multiple sclerosis and experimental autoimmune encephalomyelitis“, Dr. Schuh analyses the influence of the NLRP3in MS. NLRP is a cytosolic protein complex in monocytes, macrophages and neutrophil granolucytes that regulated the production of inflammatory cytokines of the interleukin-1 family. In her project, Dr. Schuh wants to identify the population of myeloid cells involved in MS pathogenesis, with the aim of finding new pathways for therapeutic intervention that prevent autoimmune tissue damage.
The SEED program addresses scientists younger than 32 years who have not yet completed their medical training. The maximum funding is 32.000 € or 75 percent of the project’s budget. The remaining 25% have to be paid by the stipend’s employee.